Dr. David Fajgenbaum, Author at Curetalks

Dr. David Fajgenbaum | CureTalks

"David Fajgenbaum, MD, MBA, MSc, FCPP, is an Assistant Professor of Medicine in the Division of Translational Medicine & Human Genetics at the University of Pennsylvania, Associate Director, Patient Impact of the University of Pennsylvania's Orphan Disease Center, Founding Director of the Castleman Disease Center at Penn, Co-Founder & volunteer Executive Director of the Castleman Disease Collaborative Network (CDCN), and Senior Fellow of the Leonard Davis Institute for Health Economics. Dr. Fajgenbaum leads the Castleman Research Program at Penn as PI of 18 translational research studies, including an international natural history study and the first-ever NIH R01-funded research of idiopathic multicentric Castleman disease (iMCD). His published research has changed the way iMCD is researched and treated. He is also an iMCD patient himself, who is in his longest remission ever thanks to a precision treatment that he identified, which had never been used before for iMCD."

Related Talks